Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vertigo and abacavir.

Lori E Fantry1, Hinrich Staecker

  • 1University of Maryland Medical School; Institute of Human Virology, Baltimore, Maryland, USA. lfantry@medicine.umaryland.edu

AIDS Patient Care and Stds
|February 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Capsid-engineered AAV vector overcomes a key intracellular barrier and efficiently transduces spiral ganglion neurons in adult mice.

Molecular therapy. Advances·2026
Same author

Severe and profound hearing loss in patients with multiple sensory impairments: increased incidence of cognitive impairment.

Brazilian journal of otorhinolaryngology·2026
Same author

Extracellular vesicle-mediated gene editing for the treatment of nonsyndromic progressive hearing loss in adult mice.

Science translational medicine·2025
Same author

Gene therapy for inner ear disease: the next targets.

Current opinion in otolaryngology & head and neck surgery·2025
Same author

Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE.

The lancet. HIV·2025
Same author

The Effect of Using a Standardized Questionnaire on Sexual History Documentation and Testing to Diagnose Gonorrhea and Chlamydia Among Men Who Have Sex With Men With Human Immunodeficiency Virus.

Sexually transmitted diseases·2024
Same journal

<i>Letter:</i> Limited Use of Proviral Sequencing in Adults with HIV Starting Long-Acting Injectable Cabotegravir-Rilpivirine.

AIDS patient care and STDs·2026
Same journal

Early Implementation of Doxycycline Postexposure Prophylaxis at an Infectious Diseases Clinic in the Southern United States.

AIDS patient care and STDs·2026
Same journal

Enhancing Pre-Exposure Prophylaxis Prescribing and Uptake Among Black Women in an Urban Sexually Transmitted Infections Clinic: A Quality Improvement Project.

AIDS patient care and STDs·2026
Same journal

People with HIV Continuing on Complex Regimens in the Era of Treatment Optimization: Characteristics and Outcomes.

AIDS patient care and STDs·2026
Same journal

HIV-Related Stigma Assessment Through an Integrated Digital Strategy in Routine Clinical Care.

AIDS patient care and STDs·2026
Same journal

Sexual Acquisition of HCV in Women Living with HIV: Biological Plausibility, Epidemiological Signals, and Implications for Enhanced Testing and Treatment Strategies.

AIDS patient care and STDs·2026
See all related articles

A human immunodeficiency virus (HIV) patient experienced vertigo while on abacavir therapy. Symptoms resolved upon stopping the medication, suggesting a potential link between abacavir and vertigo.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Pharmacology

Background:

  • Vertigo significantly impacts daily activities and quality of life.
  • Human immunodeficiency virus (HIV) infection requires complex antiretroviral therapy.
  • Abacavir is a nucleoside reverse transcriptase inhibitor used in HIV treatment.

Observation:

  • A patient with HIV presented with vertigo.
  • The vertigo symptoms emerged during abacavir treatment.
  • Immediate resolution of vertigo occurred upon discontinuation of abacavir.

Findings:

  • A potential adverse effect of abacavir causing vertigo was observed.
  • The temporal relationship suggests abacavir as a possible trigger for vertigo in this patient.
  • The underlying mechanism linking abacavir to vertigo remains undetermined.

Related Experiment Videos

Implications:

  • This case highlights a potential, previously unrecognized side effect of abacavir.
  • Clinicians should consider abacavir-induced vertigo in HIV patients presenting with these symptoms.
  • Further investigation is warranted to elucidate the mechanism of abacavir-associated vertigo.